{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:29:56Z","timestamp":1791973796518,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007019-46"],"award-info":[{"award-number":["T32AI007019-46"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI114780"],"award-info":[{"award-number":["AI114780"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI142198"],"award-info":[{"award-number":["AI142198"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U54-NS115054"],"award-info":[{"award-number":["U54-NS115054"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","award":["NS115054"],"award-info":[{"award-number":["NS115054"]}],"id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00401-023-02603-y","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T15:04:13Z","timestamp":1687359853000},"page":"319-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology"],"prefix":"10.1007","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-4790","authenticated-orcid":false,"given":"Minh C.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4754-2141","authenticated-orcid":false,"given":"Gianvito","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-818X","authenticated-orcid":false,"given":"Rosa","family":"Patzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9846-1045","authenticated-orcid":false,"given":"Abeer H.","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-973X","authenticated-orcid":false,"given":"Seneca R.","family":"Oxendine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-9031","authenticated-orcid":false,"given":"Sangwook","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9389-7918","authenticated-orcid":false,"given":"Aimee S.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8438-482X","authenticated-orcid":false,"given":"Richard J.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7056-419X","authenticated-orcid":false,"given":"Kevin C.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"2603_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad153","author":"NM Allen","year":"2023","unstructured":"Allen NM, O\u2019Rahelly M, Eymard B, Chouchane M, Hahn A, Kearns G et al (2023) The emerging spectrum of foetal acetylcholine receptor antibody-associated disorders (FARAD). Brain. https:\/\/doi.org\/10.1093\/brain\/awad153","journal-title":"Brain"},{"key":"2603_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-3940(96)12488-5","volume":"207","author":"D Beeson","year":"1996","unstructured":"Beeson D, Amar M, Bermudez I, Vincent A, Newsom-Davis J (1996) Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit. Neurosci Lett 207:57\u201360. https:\/\/doi.org\/10.1016\/0304-3940(96)12488-5","journal-title":"Neurosci Lett"},{"key":"2603_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C et al (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617\u2013629. https:\/\/doi.org\/10.1002\/ana.21802","journal-title":"Ann Neurol"},{"key":"2603_CR4","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet X, Lefranc MP, Giudicelli V (2008) IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36:W503-508. https:\/\/doi.org\/10.1093\/nar\/gkn316","journal-title":"Nucleic Acids Res"},{"key":"2603_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/0161-5890(95)00101-8","volume":"32","author":"A Cardona","year":"1995","unstructured":"Cardona A, Pritsch O, Dumas G, Bach JF, Dighiero G (1995) Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor. Mol Immunol 32:1215\u20131223. https:\/\/doi.org\/10.1016\/0161-5890(95)00101-8","journal-title":"Mol Immunol"},{"key":"2603_CR6","first-page":"241","volume":"144","author":"CC Chang","year":"1963","unstructured":"Chang CC, Lee CY (1963) Isolation of neurotoxins from the venom of bungarus multicinctus and their modes of neuromuscular blocking action. Arch Int Pharmacodyn Ther 144:241\u2013257","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2603_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1073\/pnas.67.3.1241","volume":"67","author":"JP Changeux","year":"1970","unstructured":"Changeux JP, Kasai M, Lee CY (1970) Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci U S A 67:1241\u20131247. https:\/\/doi.org\/10.1073\/pnas.67.3.1241","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2603_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms5167","volume":"5","author":"MJ Cho","year":"2014","unstructured":"Cho MJ, Lo AS, Mao X, Nagler AR, Ellebrecht CT, Mukherjee EM et al (2014) Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nat Commun 5:1\u201311","journal-title":"Nat Commun"},{"key":"2603_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/brain\/awz106","volume":"142","author":"E Cotzomi","year":"2019","unstructured":"Cotzomi E, Stathopoulos P, Lee CS, Ritchie AM, Soltys JN, Delmotte FR et al (2019) Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production. Brain 142:1598\u20131615. https:\/\/doi.org\/10.1093\/brain\/awz106","journal-title":"Brain"},{"key":"2603_CR10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","volume":"298","author":"DB Drachman","year":"1978","unstructured":"Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ (1978) Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 298:1116\u20131122","journal-title":"N Engl J Med"},{"key":"2603_CR11","doi-asserted-by":"publisher","first-page":"20140238","DOI":"10.1098\/rstb.2014.0238","volume":"370","author":"CJH Dunand","year":"2015","unstructured":"Dunand CJH, Wilson PC (2015) Restricted, canonical, stereotyped and convergent immunoglobulin responses. Philosoph Trans Royal Soc Biol Sci 370:20140238","journal-title":"Philosoph Trans Royal Soc Biol Sci"},{"key":"2603_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/9780470720721.ch12","author":"AG Engel","year":"1982","unstructured":"Engel AG, Fumagalli G (1982) Mechanisms of acetylcholine receptor loss from the neuromuscular junction. Ciba Found Symp. https:\/\/doi.org\/10.1002\/9780470720721.ch12","journal-title":"Ciba Found Symp"},{"key":"2603_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/intimm\/9.9.1311","volume":"9","author":"J Farrar","year":"1997","unstructured":"Farrar J, Portolano S, Willcox N, Vincent A, Jacobson L, Newsom-Davis J et al (1997) Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. Int Immunol 9:1311\u20131318. https:\/\/doi.org\/10.1093\/intimm\/9.9.1311","journal-title":"Int Immunol"},{"key":"2603_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40478-022-01454-0","volume":"10","author":"ML Fichtner","year":"2022","unstructured":"Fichtner ML, Hoehn KB, Ford EE, Mane-Damas M, Oh S, Waters P et al (2022) Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy. Acta Neuropathol Commun 10:154. https:\/\/doi.org\/10.1186\/s40478-022-01454-0","journal-title":"Acta Neuropathol Commun"},{"key":"2603_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00776","author":"ML Fichtner","year":"2020","unstructured":"Fichtner ML, Jiang R, Bourke A, Nowak RJ, O\u2019Connor KC (2020) Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00776","journal-title":"Front Immunol"},{"key":"2603_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0014-5793(00)01980-3","volume":"481","author":"E Fostieri","year":"2000","unstructured":"Fostieri E, Beeson D, Tzartos SJ (2000) The conformation of the main immunogenic region on the alpha-subunit of muscle acetylcholine receptor is affected by neighboring receptor subunits. FEBS Lett 481:127\u2013130. https:\/\/doi.org\/10.1016\/s0014-5793(00)01980-3","journal-title":"FEBS Lett"},{"key":"2603_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/eji.200425671","volume":"35","author":"E Fostieri","year":"2005","unstructured":"Fostieri E, Tzartos SJ, Berrih-Aknin S, Beeson D, Mamalaki A (2005) Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies. Eur J Immunol 35:632\u2013643. https:\/\/doi.org\/10.1002\/eji.200425671","journal-title":"Eur J Immunol"},{"key":"2603_CR18","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia Gravis. N Engl J Med 375:2570\u20132581. https:\/\/doi.org\/10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"2603_CR19","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1073\/pnas.80.13.4089","volume":"80","author":"CM Gomez","year":"1983","unstructured":"Gomez CM, Richman DP (1983) Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia. Proc Natl Acad Sci USA 80:4089\u20134093. https:\/\/doi.org\/10.1073\/pnas.80.13.4089","journal-title":"Proc Natl Acad Sci USA"},{"key":"2603_CR20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.4049\/jimmunol.158.4.1919","volume":"158","author":"YF Graus","year":"1997","unstructured":"Graus YF, de Baets MH, Parren PW, Berrih-Aknin S, Wokke J, van Breda Vriesman PJ et al (1997) Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. J Immunol 158:1919\u20131929","journal-title":"J Immunol"},{"key":"2603_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1083\/jcb.114.4.799","volume":"114","author":"Y Gu","year":"1991","unstructured":"Gu Y, Forsayeth JR, Verrall S, Yu XM, Hall ZW (1991) Assembly of the mammalian muscle acetylcholine receptor in transfected COS cells. J Cell Biol 114:799\u2013807","journal-title":"J Cell Biol"},{"key":"2603_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-2249.1991.tb05625.x","volume":"83","author":"V Guigou","year":"1991","unstructured":"Guigou V, Emilie D, Berrih-Aknin S, Fumoux F, Fougereau M, Schiff C (1991) Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the Vh and Vk families. Clin Exp Immunol 83:262\u2013266. https:\/\/doi.org\/10.1111\/j.1365-2249.1991.tb05625.x","journal-title":"Clin Exp Immunol"},{"key":"2603_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0896-6273(01)00461-5","volume":"32","author":"M Harel","year":"2001","unstructured":"Harel M, Kasher R, Nicolas A, Guss JM, Balass M, Fridkin M et al (2001) The binding site of acetylcholine receptor as visualized in the X-Ray structure of a complex between alpha-bungarotoxin and a mimotope peptide. Neuron 32:265\u2013275. https:\/\/doi.org\/10.1016\/s0896-6273(01)00461-5","journal-title":"Neuron"},{"key":"2603_CR24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamaneurol.2019.5125","volume":"77","author":"JF Howard Jr","year":"2020","unstructured":"Howard JF Jr, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL et al (2020) Clinical Effects of the Self-administered subcutaneous complement inhibitor zilucoplan in patients with moderate to severe generalized myasthenia gravis: results of a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial. JAMA Neurol 77:582\u2013592. https:\/\/doi.org\/10.1001\/jamaneurol.2019.5125","journal-title":"JAMA Neurol"},{"key":"2603_CR25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","volume":"16","author":"JF Howard Jr","year":"2017","unstructured":"Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I et al (2017) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 16:976\u2013986. https:\/\/doi.org\/10.1016\/S1474-4422(17)30369-1","journal-title":"Lancet Neurol"},{"key":"2603_CR26","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/acn3.51376","volume":"8","author":"JF Howard Jr","year":"2021","unstructured":"Howard JF Jr, Karam C, Yountz M, O\u2019Brien FL, Mozaffar T, Group ftRS (2021) Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses. Annals Clin Translat Neurol 8:1398\u20131407. https:\/\/doi.org\/10.1002\/acn3.51376","journal-title":"Annals Clin Translat Neurol"},{"key":"2603_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","volume":"21","author":"MG Huijbers","year":"2022","unstructured":"Huijbers MG, Marx A, Plomp JJ, Le Panse R, Phillips WD (2022) Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. Lancet Neurol 21:163\u2013175. https:\/\/doi.org\/10.1016\/S1474-4422(21)00357-4","journal-title":"Lancet Neurol"},{"key":"2603_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/s0165-5728(99)00086-7","volume":"98","author":"L Jacobson","year":"1999","unstructured":"Jacobson L, Beeson D, Tzartos S, Vincent A (1999) Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform. J Neuroimmunol 98:112\u2013120. https:\/\/doi.org\/10.1016\/s0165-5728(99)00086-7","journal-title":"J Neuroimmunol"},{"key":"2603_CR29","doi-asserted-by":"publisher","first-page":"30649","DOI":"10.1073\/pnas.2007206117","volume":"117","author":"R Jiang","year":"2020","unstructured":"Jiang R, Hoehn KB, Lee CS, Pham MC, Homer RJ, Detterbeck FC et al (2020) Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis. Proc Natl Acad Sci USA 117:30649\u201330660. https:\/\/doi.org\/10.1073\/pnas.2007206117","journal-title":"Proc Natl Acad Sci USA"},{"key":"2603_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrn731","volume":"3","author":"A Karlin","year":"2002","unstructured":"Karlin A (2002) Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3:102\u2013114. https:\/\/doi.org\/10.1038\/nrn731","journal-title":"Nat Rev Neurosci"},{"key":"2603_CR31","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.4049\/jimmunol.1801622","volume":"202","author":"J Koers","year":"2019","unstructured":"Koers J, Derksen NIL, Ooijevaar-de Heer P, Nota B, van de Bovenkamp FS, Vidarsson G et al (2019) Biased N-Glycosylation site distribution and acquisition across the antibody v region during B cell maturation. J Immunol 202:2220\u20132228. https:\/\/doi.org\/10.4049\/jimmunol.1801622","journal-title":"J Immunol"},{"key":"2603_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0165-5728(88)90043-4","volume":"19","author":"B Lang","year":"1988","unstructured":"Lang B, Richardson G, Rees J, Vincent A, Newsom-Davis J (1988) Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell line. J Neuroimmunol 19:141\u2013148. https:\/\/doi.org\/10.1016\/0165-5728(88)90043-4","journal-title":"J Neuroimmunol"},{"key":"2603_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/acn3.311","volume":"3","author":"JY Lee","year":"2016","unstructured":"Lee JY, Stathopoulos P, Gupta S, Bannock JM, Barohn RJ, Cotzomi E et al (2016) Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis. Ann Clin Transl Neurol 3:443\u2013454. https:\/\/doi.org\/10.1002\/acn3.311","journal-title":"Ann Clin Transl Neurol"},{"key":"2603_CR34","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP et al (2008) IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis\u2020. Brain 131:1940\u20131952. https:\/\/doi.org\/10.1093\/brain\/awn092","journal-title":"Brain"},{"key":"2603_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1309\/ajcpyeor6sge8zlu","volume":"143","author":"BK Lozier","year":"2015","unstructured":"Lozier BK, Haven TR, Astill ME, Hill HR (2015) Detection of acetylcholine receptor modulating antibodies by flow cytometry. Am J Clin Pathol 143:186\u2013196. https:\/\/doi.org\/10.1309\/ajcpyeor6sge8zlu","journal-title":"Am J Clin Pathol"},{"key":"2603_CR36","doi-asserted-by":"publisher","first-page":"e0185976","DOI":"10.1371\/journal.pone.0185976","volume":"12","author":"T Makino","year":"2017","unstructured":"Makino T, Nakamura R, Terakawa M, Muneoka S, Nagahira K, Nagane Y et al (2017) Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools. PLoS ONE 12:e0185976. https:\/\/doi.org\/10.1371\/journal.pone.0185976","journal-title":"PLoS ONE"},{"key":"2603_CR37","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.4049\/jimmunol.2100225","volume":"207","author":"C Mandel-Brehm","year":"2021","unstructured":"Mandel-Brehm C, Fichtner ML, Jiang R, Winton VJ, Vazquez SE, Pham MC et al (2021) Elevated N-Linked Glycosylation of IgG V regions in myasthenia gravis disease subtypes. J Immunol 207:2005\u20132014. https:\/\/doi.org\/10.4049\/jimmunol.2100225","journal-title":"J Immunol"},{"key":"2603_CR38","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/brain\/awaa195","volume":"143","author":"F Mannara","year":"2020","unstructured":"Mannara F, Radosevic M, Planagum\u00e0 J, Soto D, Aguilar E, Garc\u00eda-Serra A et al (2020) Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis. Brain 143:2709\u20132720. https:\/\/doi.org\/10.1093\/brain\/awaa195","journal-title":"Brain"},{"key":"2603_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875\u2013884. https:\/\/doi.org\/10.1016\/j.autrev.2013.03.007","journal-title":"Autoimmun Rev"},{"key":"2603_CR40","doi-asserted-by":"publisher","first-page":"577850","DOI":"10.1016\/j.jneuroim.2022.577850","volume":"367","author":"G Masi","year":"2022","unstructured":"Masi G, Li Y, Karatz T, Pham MC, Oxendine SR, Nowak RJ et al (2022) The clinical need for clustered AChR cell-based assay testing of seronegative MG. J Neuroimmunol 367:577850. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577850","journal-title":"J Neuroimmunol"},{"key":"2603_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1749-6632.1998.tb10957.x","volume":"841","author":"I Matthews","year":"1998","unstructured":"Matthews I, Farrar J, McLachlan S, Rapoport B, Newsom-Davis J, Willcox N et al (1998) Production of Fab Fragments against the human acetylcholine receptor from myasthenia gravis thymus lambda and kappa phage libraries a. Anna NewYork Acad Sci 841:418\u2013421","journal-title":"Anna NewYork Acad Sci"},{"key":"2603_CR42","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/01.LAB.0000032379.63784.9C","volume":"82","author":"I Matthews","year":"2002","unstructured":"Matthews I, Sims G, Ledwidge S, Stott D, Beeson D, Willcox N et al (2002) Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen. Lab Invest 82:1407\u20131417","journal-title":"Lab Invest"},{"key":"2603_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.26447","volume":"60","author":"S Muppidi","year":"2019","unstructured":"Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I et al (2019) Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. Muscle Nerve 60:14\u201324. https:\/\/doi.org\/10.1002\/mus.26447","journal-title":"Muscle Nerve"},{"issue":"2469\u20132477","key":"2603_CR44","first-page":"e2413","volume":"185","author":"CM Noviello","year":"2022","unstructured":"Noviello CM, Kreye J, Teng J, Pr\u00fcss H, Hibbs RE (2022) Structural mechanisms of GABAA receptor autoimmune encephalitis. Cell 185(2469\u20132477):e2413","journal-title":"Cell"},{"key":"2603_CR45","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001169","author":"AH Obaid","year":"2022","unstructured":"Obaid AH, Zografou C, Vadysirisack DD, Munro-Sheldon B, Fichtner ML, Roy B et al (2022) Heterogeneity of acetylcholine receptor autoantibody-mediated complement activity in patients with myasthenia gravis. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001169","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2603_CR46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1172\/JCI200112462","volume":"108","author":"AE Pugh-Bernard","year":"2001","unstructured":"Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, Insel RA et al (2001) Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Investig 108:1061\u20131070","journal-title":"J Clin Investig"},{"key":"2603_CR47","doi-asserted-by":"publisher","first-page":"e1122","DOI":"10.1212\/nxi.0000000000001122","volume":"9","author":"M Radosevic","year":"2022","unstructured":"Radosevic M, Planagum\u00e0 J, Mannara F, Mellado A, Aguilar E, Sabater L et al (2022) Allosteric modulation of nmdars reverses patients\u2019 autoantibody effects in mice. Neurol Neuroimmunol Neuroinflam 9:e1122. https:\/\/doi.org\/10.1212\/nxi.0000000000001122","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"2603_CR48","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.neuron.2020.03.012","volume":"106","author":"MM Rahman","year":"2020","unstructured":"Rahman MM, Teng J, Worrell BT, Noviello CM, Lee M, Karlin A et al (2020) Structure of the native muscle-type nicotinic receptor and inhibition by snake venom toxins. Neuron 106:952\u2013962. https:\/\/doi.org\/10.1016\/j.neuron.2020.03.012","journal-title":"Neuron"},{"key":"2603_CR49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00401-022-02493-6","volume":"144","author":"N Rose","year":"2022","unstructured":"Rose N, Holdermann S, Callegari I, Kim H, Fruh I, Kappos L et al (2022) Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities. Acta Neuropathol 144:1005\u20131025. https:\/\/doi.org\/10.1007\/s00401-022-02493-6","journal-title":"Acta Neuropathol"},{"key":"2603_CR50","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","volume":"167","author":"GP Sims","year":"2001","unstructured":"Sims GP, Shiono H, Willcox N, Stott DI (2001) Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol 167:1935\u20131944. https:\/\/doi.org\/10.4049\/jimmunol.167.4.1935","journal-title":"J Immunol"},{"key":"2603_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","volume":"4","author":"K Smith","year":"2009","unstructured":"Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R et al (2009) Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 4:372\u2013384. https:\/\/doi.org\/10.1038\/nprot.2009.3","journal-title":"Nat Protoc"},{"key":"2603_CR52","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1172\/JCI122942","volume":"129","author":"J Soltys","year":"2019","unstructured":"Soltys J, Liu Y, Ritchie A, Wemlinger S, Schaller K, Schumann H et al (2019) Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica. J Clin Invest 129:2000\u20132013. https:\/\/doi.org\/10.1172\/JCI122942","journal-title":"J Clin Invest"},{"key":"2603_CR53","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/wnl.0000000000003713","volume":"88","author":"M Spatola","year":"2017","unstructured":"Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Barcelo Artigues MI et al (2017) Investigations in GABA(A) receptor antibody-associated encephalitis. Neurology 88:1012\u20131020. https:\/\/doi.org\/10.1212\/wnl.0000000000003713","journal-title":"Neurology"},{"key":"2603_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jneuroim.2005.01.009","volume":"162","author":"I Spreadbury","year":"2005","unstructured":"Spreadbury I, Kishore U, Beeson D, Vincent A (2005) Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation. J Neuroimmunol 162:149\u2013156. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.01.009","journal-title":"J Neuroimmunol"},{"key":"2603_CR55","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.4049\/jimmunol.1801295","volume":"202","author":"P Stathopoulos","year":"2019","unstructured":"Stathopoulos P, Chastre A, Waters P, Irani S, Fichtner ML, Benotti ES et al (2019) Autoantibodies against neurologic antigens in nonneurologic autoimmunity. J Immunol 202:2210\u20132219. https:\/\/doi.org\/10.4049\/jimmunol.1801295","journal-title":"J Immunol"},{"key":"2603_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94263","author":"P Stathopoulos","year":"2017","unstructured":"Stathopoulos P, Kumar A, Nowak RJ, O\u2019Connor KC (2017) Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.94263","journal-title":"JCI Insight"},{"key":"2603_CR57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/mus.880090404","volume":"9","author":"R Sterz","year":"1986","unstructured":"Sterz R, Hohlfeld R, Rajki K, Kaul M, Heininger K, Peper K et al (1986) Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab\u2019)2 hybrid molecules. Muscle Nerve 9:306\u2013312. https:\/\/doi.org\/10.1002\/mus.880090404","journal-title":"Muscle Nerve"},{"key":"2603_CR58","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.4049\/jimmunol.1502193","volume":"197","author":"KY Su","year":"2016","unstructured":"Su KY, Watanabe A, Yeh CH, Kelsoe G, Kuraoka M (2016) Efficient culture of human naive and memory B cells for Use as APCs. J Immunol 197:4163\u20134176. https:\/\/doi.org\/10.4049\/jimmunol.1502193","journal-title":"J Immunol"},{"key":"2603_CR59","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127167","author":"K Takata","year":"2019","unstructured":"Takata K, Stathopoulos P, Cao M, Man\u00e9-Damas M, Fichtner ML, Benotti ES et al (2019) Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.127167","journal-title":"JCI Insight"},{"key":"2603_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 329:112\u2013124. https:\/\/doi.org\/10.1016\/j.jim.2007.09.017","journal-title":"J Immunol Methods"},{"key":"2603_CR61","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1749-6632.1981.tb33741.x","volume":"377","author":"RS Tindall","year":"1981","unstructured":"Tindall RS (1981) Humoral immunity in myasthenia gravis: clinical correlations of anti-receptor antibody avidity and titer. Ann N Y Acad Sci 377:316\u2013331. https:\/\/doi.org\/10.1111\/j.1749-6632.1981.tb33741.x","journal-title":"Ann N Y Acad Sci"},{"key":"2603_CR62","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.1179220","volume":"190","author":"KV Toyka","year":"1975","unstructured":"Toyka KV, Brachman DB, Pestronk A, Kao I (1975) Myasthenia gravis: passive transfer from man to mouse. Science 190:397\u2013399. https:\/\/doi.org\/10.1126\/science.1179220","journal-title":"Science"},{"key":"2603_CR63","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ana.22657","volume":"71","author":"L Tradtrantip","year":"2012","unstructured":"Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC et al (2012) Anti\u2013Aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 71:314\u2013322","journal-title":"Ann Neurol"},{"key":"2603_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","volume":"15","author":"S Tzartos","year":"1987","unstructured":"Tzartos S, Hochschwender S, Vasquez P, Lindstrom J (1987) Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J Neuroimmunol 15:185\u2013194. https:\/\/doi.org\/10.1016\/0165-5728(87)90092-0","journal-title":"J Neuroimmunol"},{"key":"2603_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-065x.1998.tb01190.x","volume":"163","author":"SJ Tzartos","year":"1998","unstructured":"Tzartos SJ, Barkas T, Cung MT, Mamalaki A, Marraud M, Orlewski P et al (1998) Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev 163:89\u2013120. https:\/\/doi.org\/10.1111\/j.1600-065x.1998.tb01190.x","journal-title":"Immunol Rev"},{"key":"2603_CR66","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1073\/pnas.77.2.755","volume":"77","author":"SJ Tzartos","year":"1980","unstructured":"Tzartos SJ, Lindstrom JM (1980) Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 77:755\u2013759. https:\/\/doi.org\/10.1073\/pnas.77.2.755","journal-title":"Proc Natl Acad Sci USA"},{"key":"2603_CR67","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1073\/pnas.79.1.188","volume":"79","author":"SJ Tzartos","year":"1982","unstructured":"Tzartos SJ, Seybold ME, Lindstrom JM (1982) Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci 79:188\u2013192","journal-title":"Proc Natl Acad Sci"},{"key":"2603_CR68","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.4049\/jimmunol.134.4.2343","volume":"134","author":"SJ Tzartos","year":"1985","unstructured":"Tzartos SJ, Sophianos D, Efthimiadis A (1985) Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera. J Immunol 134:2343\u20132349","journal-title":"J Immunol"},{"key":"2603_CR69","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","volume":"12","author":"JJ Verschuuren","year":"2013","unstructured":"Verschuuren JJ, Huijbers MG, Plomp JJ, Niks EH, Molenaar PC, Martinez-Martinez P et al (2013) Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmun Rev 12:918\u2013923. https:\/\/doi.org\/10.1016\/j.autrev.2013.03.001","journal-title":"Autoimmun Rev"},{"key":"2603_CR70","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nri916","volume":"2","author":"A Vincent","year":"2002","unstructured":"Vincent A (2002) Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2:797\u2013804. https:\/\/doi.org\/10.1038\/nri916","journal-title":"Nat Rev Immunol"},{"key":"2603_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaut.2013.12.008","volume":"52","author":"K Vrolix","year":"2014","unstructured":"Vrolix K, Fraussen J, Losen M, Stevens J, Lazaridis K, Molenaar PC et al (2014) Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor. J Autoimmun 52:101\u2013112. https:\/\/doi.org\/10.1016\/j.jaut.2013.12.008","journal-title":"J Autoimmun"},{"key":"2603_CR72","doi-asserted-by":"publisher","first-page":"2100066","DOI":"10.1056\/EVIDoa2100066","volume":"1","author":"T Vu","year":"2022","unstructured":"Vu T, Meisel A, Mantegazza R, Annane D, Katsuno M, Aguzzi R et al (2022) Terminal complement inhibitor ravulizumab in generalized myasthenia gravis. NEJM Evid 1:2100066. https:\/\/doi.org\/10.1056\/EVIDoa2100066","journal-title":"NEJM Evid"},{"key":"2603_CR73","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC (2003) Predominant autoantibody production by early human B cell precursors. Science 301:1374\u20131377. https:\/\/doi.org\/10.1126\/science.1086907","journal-title":"Science"},{"key":"2603_CR74","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1172\/JCI44425","volume":"120","author":"J Yamagami","year":"2010","unstructured":"Yamagami J, Payne AS, Kacir S, Ishii K, Siegel DL, Stanley JR (2010) Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity. J Clin Investig 120:4111\u20134117","journal-title":"J Clin Investig"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-023-02603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-023-02603-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-023-02603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T07:13:24Z","timestamp":1688714004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-023-02603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2603"],"URL":"https:\/\/doi.org\/10.1007\/s00401-023-02603-y","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Aimee S. Payne has received equity, research support, patent licensing and other payments from Cabaletta Bio; patent licensing payments from Novartis; and consultant fees from Janssen. Dr. Sangwook Oh has received patent licensing payments from Cabaletta Bio. Dr. Richard J. Nowak has received research support from the NIH, Genentech, Alexion Pharmaceuticals, argenx, Annexon Biosciences, UCB Ra Pharmaceuticals, Myasthenia Gravis Foundation of America, Momenta, Immunovant, Grifols, and Viela Bio, now (Horizon Therapeutics). RJN has served as consultant\/ advisor for Alexion Pharmaceuticals, argenx, Cabaletta Bio, CSL Behring, Grifols, Ra Pharmaceuticals, now a part of UCB Pharma, Immunovant, Momenta, and Viela Bio, now a part of Horizon Therapeutics; Dr. Kevin C. O\u2019Connor has received research support from Ra Pharma, now (UCB Pharma), Alexion, now (AstraZeneca), Viela Bio, now (Horizon Therapeutics), and argenx. KCO is a consultant and equity shareholder of Cabaletta Bio. KCO has served as a consultant\/advisor for Alexion Pharmaceuticals, now (AstraZeneca), and Roche. The authors have no additional financial interests. All other authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Deidentified human-derived specimens were retrieved from a biorepository established at the Yale University School of Medicine under the approval of Yale University\u2019s Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants"}}]}}